Leaflet RALAGO 1mg tablets
Indicated for: Parkinson's disease
Route of administration: oral
Substance: rasagiline (antiparkinsonian agent)
ATC: N04BD02 (Nervous system | Dopaminergic agents | Monoamine oxidase B inhibitors)
This medicine may affect your ability to drive or use machines.
This medicine may cause dizziness or vertigo.
May lower blood pressure and increase the risk of falls.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
This medicine may cause drowsiness or reduced alertness.
Rasagiline is a medication used to treat Parkinson's disease, a neurodegenerative condition characterized by tremors, rigidity, and movement difficulties. It is a selective monoamine oxidase type B (MAO-B) inhibitor that increases dopamine levels in the brain, thereby alleviating symptoms of the disease.
The medication is taken orally, usually in tablet form, and should be used as directed by your doctor. It is important to follow the prescribed dosage and avoid tyramine-rich foods, such as aged cheeses, to prevent adverse reactions.
Side effects may include headache, dizziness, nausea, or insomnia. In rare cases, severe adverse effects such as high blood pressure or allergic reactions may occur, requiring immediate medical attention.
Patients should inform their doctor about any other medications being used or pre-existing conditions, such as depression or hypertension, to ensure the safe use of rasagiline.
General data about RALAGO 1mg
- Substance: rasagiline
- Date of latest medicines list: 01-03-2022
- Product code: W62316004
- Concentration: 1mg
- Pharmaceutical form: tablets
- Quantity: 30
- Product type: Generic medicine
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.